55 results about "Vaginal bleeding" patented technology

The invention belongs to the technical field of traditional Chinese medicines, and discloses a Shenghua decoction added with Radix Codonopsis for preventing intrauterine adhesion after artificial abortion and a preparation method of the Shenghua decoction. The Shenghua decoction added with Radix Codonopsis for preventing intrauterine adhesion after artificial abortion consists of Radix Codonopsis,Radix Astragali, Semen Persicae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Rhizoma Zingiberis Preparatum, Herba Leonuri, Pollen Tyjphae (parched), Fructus Aurantii (parched), Herba Taraxaci, Radix Cyathulae and Radix Glycyrrhizae Preparata. Medicines are added or reduced on the basis of the formula. By the Shenghua decoction added with Radix Codonopsis for preventing intrauterine adhesion after artificial abortion, the time of vaginal bleeding after induced abortion can be shortened; first menstrual resurgence after induced abortion is improved; postoperative periodic abdominal pain is improved; and uterine cavity adhesion rate is reduced. The medicine taking types of patients are reduced, and the cost of the patients is saved; the medicine taking period and the visiting times of thepatients are reduced, and the cost of the patients is reduced; the postoperative uterine cavity adhesion rate is reduced, the possibility of secondary operation is reduced, and the hospitalization frequency of the patients is reduced, so that the expenditure of the patients and national medical insurance can be reduced; The formula has a remarkable curative effect, the influence of traditional Chinese medicines is expanded, and the propaganda cost of traditional Chinese medicine culture is indirectly saved. The new medicine provided by the invention can effectively reduce adverse reaction after induced abortion; and the influence of the traditional Chinese medicine is expanded, and Chinese cultural legacy is promoted.

The invention discloses a traditional Chinese medicine composition for fetus protection, relating to the field of a traditional Chinese medicine. The traditional Chinese medicine composition is prepared from the following active ingredients in parts by weight: 10-14 parts of radix angelicae sinensis, 10-14 parts of rhizome chuanxiong, 9-15 parts of rhizoma cyperi, 9-15 parts of radix rehmanniae preparata, 10-14 parts of dipsacus, 9-15 parts of colla corii asini, 9-15 parts of radix saposhnikoviae, 10-14 parts of stir-fried cacumen platyclad, 9-15 parts of stir-fried typha pollen, 10-14 parts of stir-fried gardenia, 9-15 parts of radix polygalae, 9-15 parts of stir-fried radix sanguisorbae, 9-15 parts of radix glycyrrhizae and 10-14 parts of radix paeoniae alba. The traditional Chinese medicine composition for protection is good in treatment effect and free from toxic and side effects; the traditional Chinese medicine composition is a fetus protection medicament aiming at the phenomena of having colporrhagia, fetal movement tenesmus, lumbar and abnormal distenition bearing-down pain with annoyance and anxiety during pregnancy duration; by combining the modern traditional Chinese medicine theory, the traditional Chinese medicine composition adopts a combination formula of the monarch and his subjects, assistant and envoy, all active ingredients are recombined so as to tonify qi and nourish blood and reinforce the kidney and prevent miscarriage. The traditional Chinese medicine composition is used for early threatened abortion belonging to traditional Chinese medicine deficiency of kidney-yin syndromes including waist soreness and swelling pain, bearing-down paint of a lower abdomen, colporrhagia, with diazzness and tinnitus, dry throat, fatigue and weakness, and feverish palms and soles.

The invention relates to a traditional Chinese medicine for clearing embryonic tissues and a preparation method and an application thereof. The traditional Chinese medicine is made from the following raw material medicines in parts by weight: 9-22 parts of ground beeltle, 12-27 parts of leonurus, 4-14 parts of rhizoma sparganii, 4.2-14.5 parts of curcuma zedoary, 6-13.7 parts of peach kernel, 5-16.4 parts of safflower, 1.3-5.8 parts of rheum officinale, 1.2-8 parts of pollen typhae, 6-16 parts of red peony root, 8-24.5 parts of radices trichosanthis, 5-13 parts of corydalis tuber, 5.1-17 parts of radix clematidis, 5-13 parts of talc, 5-15.8 parts of rhizoma alismatis, 5-18.6 parts of angelica and 5-12 parts of radix cyathulae. The traditional Chinese medicine provided by the invention has the function of removing blood stasis, and thus is capable of clearing placenta tissues left in a uterus and promoting the uterus to contract, and the traditional Chinese medicine is singly used or cooperatively used with mifepristone to obviously accelerate the discharge of the fertilized egg, obviously reduce colporrhagia, shorten the bleeding time and obviously improve the clearing rate of embryonic residues in the uterine cavity.

The invention belongs to the technical field of medicine, and relates to a traditional Chinese medicine for treating vaginal bleeding after medical abortion. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 9-15 parts of Panax ginseng, 20-28 parts of Angelica sinensis, 6-12 parts of Ligusticum chuanxiong, 3-9 parts of Semen Persicae, 2-4 parts of dried ginger, 2-4 parts of processed radix glycyrrhizae, 20-28 parts of Agrimonia pilosa, 20-28 parts of lotus rhizome node, 9-15 parts of Hibiscus rosa-sinensis flower, 7-13 parts of Radix Rubiac Cordifoliae, 6-12 parts of Fineleaf Schizonepeta Herb, 7-13 parts of Paeonia suffruticosa bark, 7-13 parts of ass-hide glue, 2-4 parts of Squama manitis, 3-9 parts of parched Vaccaria segetalis, 3-9 parts of Radix Arnebiae, 3-9 parts of Scrophularia ningpoensis, and 2-4 parts of Panax notoginseng powder. According to clinical trial results, the cure rate is 82.0% and the total effective rate is 98.0% in the observation group of the traditional Chinese medicine provided by the invention, which are both significantly higher than the cure rate (62.5%) and the total effective rate (81.3%) in the control group, with significant difference (P<0.05), the vaginal bleeding period is short, and proportion of the complete curettage of uterine cavity is low.

The invention relates to a building method of a preoperative autologus blood donation system for late trimester of pregnancy. A 300ml sealing triple bag system is adopted, the content of anticoagulants in a blood bag is increased, autologus blood of 200 ml is collected, and the anticoagulants and the blood are mixed evenly after the blood is collected and then are stored in a blood storage refrigerator of 4+ / -2.0 DEG C; the blood storage time is 15-35 days before the surgery is performed; objects with autologus blood collected are puerperae with the autologus blood donation indications, and the autologus blood donation indications are puerperae who do not have presentations of parturition signs, vaginal bleeding, growth restriction of fetuses or intrauterine hypoxia and are stable in state of illness after diseases of a cardiovascular system, diabetes, hypertensive disorder complicating pregnancy, infectious diseases and medical complications are excluded. The scientific evidence is provided for standard building of a preoperative autologus blood donation technology for late trimester of pregnancy, and therefore preoperative autologus blood donation is better applied to patients of obstetrics, the system is safer, more effective and more economical, and application and popularization of the preoperative autologus blood donation in the obstetrics are better promoted.

Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.

Methods for treating FSH related conditions, such as prostatic intraepithelial neoplasia, pedophilia, infertility, or vaginal bleeding, with GnRH antagonists are disclosed. The methods of the invention generally feature administering to a subject a GnRH antagonist suitable for in vivo administration and able to reduce both plasma FSH and LH levels in a subject, in an amount or in a formulation effective to reduce plasma FSH levels in the subject to a symptom alleviating level. In vitro fertilization and male contraceptive methods are also provided.

The invention discloses a pharmaceutical composition for treating precocious puberty and a preparation method thereof. The pharmaceutical composition for treating precocious puberty in infants comprises the following raw materials: raw rehmannia, Alisma, Digupi, Moutan cortex, Gentiana, Prunella vulgaris, malt, turtle shell, chrysanthemum, kelp, scrophulariaceae, Gallus gallis, and oyster. The preparation method of the pharmaceutical composition comprises the following steps: S1, decocting malt for 2 to 5 times, combining the decoctions and filtering, adding an equal amount of ethanol to the filtrate, stirring the mixture and standing overnight, taking the supernatant and recovering the ethanol until free Alcoholic taste, set aside; S2, grind turtle shells and oysters into powder, put them into a cloth bag, add water to decoct with other medicinal materials for 2-5 times, combine the decoction and filter, obtain the filtrate and let it stand overnight; S3, take S2 The supernatant of the filtrate is added to the supernatant of S1 and filtered, and the pharmaceutical composition is obtained through post-processing. The invention has the effects of clearing liver and dispelling stagnation, nourishing yin and purging fire, can treat young girls' breast distension and pain and vaginal bleeding, and has the effect of treating children's precocious puberty.

The invention provides medicine composition for treating colporrhagia in woman climacterium. The medicine composition comprises a first active component, namely, components of a Kuntai capsule and a second active component, namely, mifepristone, wherein the Kuntai capsule comprises cooked rehmannia roots, rhizoma coptidis, radix paeoniae alba, radix scutellariae, ass-hide glue and poria cocos. Through combined application of the Kuntai capsule and the mifepristone of the composition, the composition is obvious superior to a singleprescription of the same dosage in effect of treating the colporrhagia in the woman climacterium, the fact indicates that the two medicines have synergistic effects when being combined for usage, and meanwhile, the composition is free of obvious toxicity and side effects and more significant in treatment effect.

The invention discloses an application of parasitic loranthus total polysaccharides in preparation of an antiabortifacient. The parasitic loranthus total polysaccharides can promote pregnancy deciduas, and expression of estrogen and progestrone receptor of an ovary of an animal model, and can improve serum E2 and P level; secretion within the gestation period is adjusted; colporrhagia of the animal model is reduced; the abortion frequency is lowered; the abortion rate is lowered; gestation of rats is protected from multiple levels and factors; the miscarriage prevention effect is significant; and the curative effect is more excellent than those of parasitic loranthus total extracts.

The invention relates to a preparation method for a medicament for treating colporrhagia caused by medical abortion. The method comprises the following steps: adding 22,000ml of water into 9 grams of rubus setchuenensis bur, 6 grams of scutellaria indica, 5 grams of lindera communis, 8 grams of alpinia zerumbet, 6 grams of meliosma rigida, 8 grams of korean raspberry root, 7 grams of japanese pachysandra herb, 3 grams of asparagus fern, 2 grams of pogostemon auricularius, 3 grams of pilea cavaleriei, 6 grams of cold white grass, 7 grams of microcos paniculata, 3 grams of spreading violet, 6 grams of filipendula palmate, 5 grams of campylotropis macrocarpa, 3 grams of great willowherb herb, 6 grams of equisetum silvaticum and 2 grams of dicliptera chinensis, putting the materials into a flask with a condenser, heating the flask under 80 DEG C for 6 hours, filtrating, and collecting filtrate. The medicament for treating the colporrhagia caused by the medical abortion, prepared by the method disclosed by the invention, has a reasonable formula and a definite effect and can effectively treat the colporrhagia caused by the medical abortion.

The invention relates to a medicine for treating vaginal bleeding after medical abortion. The medicine is prepared from the following medicinal raw materials in parts by weight: 80 parts of scorzonera albicaulis bunge, 70 parts of pink reineckea herb, 60 parts of helicteres isora, 55 parts of schisandra lancifolia, 50 parts of pampanin shuteria herb, 55 parts of sida acuta, 45 parts of primula efarinosa pax, 35 parts of cissus hexangularis and 30 parts of licorice root. The medicine is reasonable in formula and exact in curative effect, and can be used for effectively treating vaginal bleeding after medical abortion.